Canaan Partners IX LLC, Director, 10% Owner at CytomX Therapeutics, Inc. (CTMX), sold 38,459 shares at $11.33 ($444K) on 2016-11-28, disclosed to the SEC on 2016-11-28.
Open-market sale of $444k CTMX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.84 | 10,890 | $129K | 29.0% |
| 2 | $11.79 | 6,729 | $79K | 17.9% |
| 3 | $11.33 | 20,840 | $236K | 53.1% |
| Total | $11.55 avg | 38,459 | $444K | 100% |
| Filing → |
| CTMX | SELL | 2016-11-16 | $593K | — | Filing → |
| CTMX | SELL | 2016-11-10 | $303K | — | Filing → |
| CTMX | SELL | 2016-06-10 | $487K | — | Filing → |